Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.
| Image |  |
|---|---|
| Description | scientific article published on 10 March 2009 |
| Author/s |
author: Mark R. Lackner Zora Modrusan |
| Publication date | March 10, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |